Chinese logistics service provider Dekun has raised 500 million yuan ($70 million) led by China’s BOCG Investment while Atom Bioscience has secured $30 million in a Series B round led by Sequoia Capital China and Hong Kong-listed Livzon Pharm.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in